ICCR Dataset for the Reporting of Neoplasms of the Heart, Pericardium, and Great Vessels Dataset Authoring Committee, Department of Laboratory Medicine & Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55902, USA.
Cardiovascular Pathology, Azienda Ospedaliera, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, Padua, Italy.
Virchows Arch. 2023 Feb;482(2):303-309. doi: 10.1007/s00428-022-03473-7. Epub 2022 Dec 13.
The International Collaboration on Cancer Reporting (ICCR) was founded by major pathology organizations from around the world to produce internationally standardized and evidence-based datasets for pathologists' reporting of cancer. Its goal is to improve cancer patient outcomes worldwide and to advance international benchmarking in cancer management. The ICCR cancer dataset development schedule is aligned with revisions of the WHO Classification of Tumours ("Blue Book") series, and in 2015 ICCR developed an initial series of thoracic datasets including a dataset for neoplasms of the heart, pericardium, and great vessels. This edition has now been updated to align with the 2021 WHO Blue Book series. An expert panel was convened to review and revise the dataset. While the majority of ICCR datasets are focused on malignant tumors, the scope of this dataset includes a number of benign tumors and tumor-like entities because of the rarity of cardiac malignancies and the serious implications of even histologically benign lesions. Due to the rarity of cardiac tumors, evidence in support of reporting elements is limited.
国际癌症报告协作组织（ICCR）由来自世界各地的主要病理学组织成立，旨在为病理学家报告癌症生成国际标准化和基于证据的数据集。其目标是改善全球癌症患者的预后，并推进癌症管理的国际基准制定。ICCR 癌症数据集的开发计划与世界卫生组织肿瘤分类（“蓝皮书”）系列的修订保持一致，并且在 2015 年 ICCR 开发了一系列初始的胸部数据集，包括心脏、心包和大血管肿瘤数据集。本版现已更新，以与 2021 年世界卫生组织蓝皮书系列保持一致。召集了一个专家小组来审查和修改数据集。虽然大多数 ICCR 数据集都集中在恶性肿瘤上，但由于心脏恶性肿瘤的罕见性以及即使是组织学良性病变也会产生严重影响，因此该数据集包括许多良性肿瘤和肿瘤样实体。由于心脏肿瘤的罕见性，支持报告要素的证据有限。
